Alira Health

The Promise and Reality of NGTs

Watch and Listen to 2022’s Summer Special episode

Our Transformation Talks Summer Special is here!

Next Generation Therapies (NGTs) currently in development will deliver treatments that address the underlying cause of diseases, disrupt the biopharmaceutical environment, and offer a life-long solution to patients. They create unprecedented opportunities for patients and will be measurable in lives saved, disabilities reduced, and overall quality of life improvements. However, along with these benefits come unprecedented challenges for insurance coverage, reimbursement, and payment.

Tune in to learn about risks and challenges in developing NGTs, bringing them to the market, and how NGTs can change patients’ lives once their value is understood and correctly attributed by the decision makers / payers.

Watch the episode “The Promise and Reality of NGTs”:
Listen to the episode:


The episode “The Promise and Reality of NGTs” is also available on the following platforms:
Google Podcasts      Spotify

Meet our speakers:

You can also learn more about next generation therapies in our latest white paper, Advanced Therapies Medicinal Products: Access, Pricing, and Ethical Issues in Perspective.

Webinars
Published on:
July 20, 2022
Meet our speakers:
Andrea Mantovani

Andrea Mantovani

Vice President, Global Market Access and Pricing, Alira Health
Oswald Bentinck headshot

Oswald Bentinck

Vice President - Head of Market Access EMEA, Novartis Gene Therapies
Pietro Sternini headshot

Pietro Sternini

Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies
Meet our host:
Kenny Carberry

Kenny Carberry

Director, Clinical Development, Alira Health

Related news

Webinars March 28, 2025
How Sustainability and Health Equity Are Reshaping Market Access Policy in Europe
This webinar will explore sustainability and health equity impact on reimbursement and procurement decisions in Europe and provide practical insights on how companies can adapt to the new landscape.
EU Market Access Sustainability
Articles March 6, 2025
ATMPs: Access, Pricing, and Ethical Issues in Perspective
Start reading this sneak peek of our recent analysis of access, pricing and ethical issues for advanced therapies medicinal products.
Advanced Therapies Market Access Orphan Drug Pricing
Articles February 17, 2025
Sustainable Pricing: An Opportunity to Improve Patient Access
Discover key pricing strategies to improve pharmaceutical health equity and price sustainability.
Market Access Pricing Sustainability
Articles January 24, 2025
How to Navigate the JCA Era: Market Access Strategy Optimization in the EU
With the JCA now in effect, we spoke with Andrea Mantovani, Alira Health Partner, Market Access and Pricing, about its impact on pharmaceutical companies hoping to bring new therapies to market.
EU Market Access
News January 8, 2025
Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London
Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)
Health Policy Market Access Pharma
Articles December 18, 2024
Market Access and Pricing Landscape for Diagnostic Radiopharmaceuticals
Discover the current market access and pricing landscape for diagnostic radiopharmaceuticals in key European markets, including the specific challenges, and discusses best practices(...)
Market Access Pricing Radiopharmaceuticals
Reports December 12, 2024
Biologics and Advanced Therapies Contract Manufacturing: Public Market Update
Gain a comprehensive analysis of publicly traded companies in the sector, including the performance and strategies of global leaders, regional specialists, and niche innovators, providing(...)
Advanced Therapies Biologics CDMO
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.